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Abstract
Background: Persistent organic pollutants (POPs) such as polychlorinated dibenzo-p-dioxins/furans, polychlorinated
biphenyls (PCBs) and organochlorine pesticides can cause a series of adverse effects on e.g. reproduction in animals and
humans, many of which involve the aryl hydrocarbon receptor (AhR). The aim of the present study was to compare the
integrated serum level of AhR mediated activity among European and Inuit populations, and evaluate whether the activity
was associated to the selected POP markers, 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis(p-
chlorophenyl)-ethylene (p,p'-DDE).
Methods: The study included 338 males from Greenland (Inuit's), Sweden, Warsaw (Poland) and Kharkiv (Ukraine). The
AhR transactivity of serum extracts alone (AhRag) and competitive AhR activity (AhRcomp) upon co-exposure with
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) were determined in the lipophilic serum fraction containing the POPs using
the AhR mediated luciferase reporter Hepa1.12cR cell assay.
Results: The European groups showed higher median level of AhR-TEQ (TCDD toxic equivalents) compared to the
Inuit's, whereas higher incidence of Inuits sample further induced AhRcomp activity. Neither AhRag nor AhR-TEQ were
correlated to CB-153 or p,p'-DDE for any of the study groups. Multiple regressions showed a significant heterogeneity
of association between the CB-153 and the AhRcomp across the study groups, and accordingly a negative association
between AhRcomp and CB-153 was found for the Kharkiv group.
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Environmental Health: A Global Access Science Source 2006, 5:14 http://www.ehjournal.net/content/5/1/14Conclusion: No consistent correlation between AhR activities and two POP markers was found. Although the
difference of AhRag between European and Inuit men could not be explained by CB-153 or p,p'-DDE levels alone, we
believe that the variation of AhR serum activity reflects different pattern of POP exposure, genetics and/or life style
factors.
1. Background
The polychlorinated dibenzo-p-dioxins/furans (PCDDs/
PCDFs), polychlorinated biphenyls (PCBs) and organo-
chlorine pesticides, such as 2,2-bis(p-chlorophenyl)-
1,1,1-trichloroethane (DDT), are prominent among the
persistent organic pollutants (POPs). Owing to their neg-
ative effects on wildlife and human health, PCBs and DDT
were restricted or totally banned in most countries during
the 1970s. However, PCBs can still be released into the
environment from poorly maintained hazardous waste
site and illegal or improper dumping of PCB wastes like
leaking from old electrical transformers, and DDT is still
used in some developing countries [1]. Being resistant to
both biotic and abiotic degradation, DDT (mainly as its
major metabolite, 1,1-dichloro-2.2-bis (p-chlorophenyl)-
ethylene (p,p'-DDE)) and PCBs bioaccumulate and mag-
nify in animals and humans [2,3]. Residues have been
detected in various food substances and in human adi-
pose tissue, milk, and serum [1,4]. While PCBs and DDT
contamination is ubiquitous globally, a high intake of fish
and sea mammal food in the Arctic regions is associated
with extraordinary high exposure [5,6]. Also Swedish fish-
erman's families of the Baltic Sea with a high consump-
tion of herring and salmon being contaminated with
POPs, constitute a highly exposed group [7,8]. For the
general populations in Eastern Europe, the burden of
POPs has been less systematically examined [9,10].
It has been documented that exposure to POPs such as
dioxins (e.g. 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD)
and dioxin-like compounds (DLCs) such as non-ortho and
mono-ortho PCBs may cause a series of negative effects
both in animal experiments and in human epidemiologic
studies including carcinogenicity [11], immunotoxicity
and adverse effects on reproductive, neurobehavioral
[12]. The toxicity of dioxins and DLCs is mediated mainly
through binding to the aryl hydrocarbon receptor (AhR),
which is an intracellular ligand-dependent transcriptional
factor expressed in most tissues of mammals [13]. Upon
receptor-ligand binding and translocation to the nucleus,
the complex with the AhR nuclear translocator binds to
the DNA dioxin-responsive elements, causing induction
of gene transcription, for instance, encoding for metabolic
enzymes [14]. More recently, interference of POPs or their
metabolites with hormone receptors has also been
observed [15,16]. Previous studies demonstrated the pres-
ence of a two-way cross talk between the intracellular sig-
nalling pathways involving the estrogen- (ER), androgen-
(AR) and the Ah- receptor [17]. Several studies on wildlife
and laboratory animals showed that exposure to PCBs
and p,p'-DDE can affect reproductive and endocrine func-
tions [5,18]. However, human epidemiologic data are
limited and major gaps in knowledge continue to pre-
clude evidence based risk assessment.
Since dioxins and DLCs exist as complex mixtures of vari-
ous congeners throughout the environment, the concept
of TEQ (TCDD toxic equivalent) has been introduced to
simplify risk assessment and regulatory control [3]. The
classical TEQs are calculated by multiplying the concen-
tration of individual PCDDs/PCDFs/PCBs by their respec-
tive Toxic Equivalency Factors (TEFs), which correspond
to the relative potency of the congener to generate AhR-
mediated effects in relation to TCDD, the most potent
AhR ligand. Previous studies emphasize that assessment
of the toxicological potential of a chemical mixture is
much more complex than can be deduced by a given cal-
culated TEQ value [5,19]. There are several drawbacks
using the TEF concept for risk assessment of mixtures of
POPs such as expensive and time consuming gas chroma-
tography mass spectrometry (GC-MS) determinations,
small concentrations of individual congeners, presence of
compounds not routinely measured or unknown sub-
stances with AhR affinity, the lack of TEF values for several
POPs, and possible antagonistic or synergistic interactions
between POPs [20-22]. Thus there is a need for an inte-
grated risk assessment of dioxins and DLCs. The in vitro
AhR mediated chemical activated luciferase gene expres-
sion (CALUX) bioassay has proven to be a quick and sen-
sitive assay to detect the AhR mediated potential of pure
chemicals [20-23], extracts of environmental and biologi-
cal matrices and thus the integrated TEQ value (CALUX-
TEQ) of complex mixtures as found in sediment, pore
water, bovine and human milk, human serum and follic-
ular fluid [24].
This study was a part of the EU supported research project
Inuedo [25] with the main objective to elucidate the fertil-
ity in European and Inuit groups with different intake of
POPs [26,27]. The 2,2',4,4',5,5'-hexachlorobiphenyl (CB-
153) and p,p'-DDE were selected as proxy biomarkers of
POPs exposure because CB-153 generally correlates with
serum total PCB concentration and chemical derived TEQ
[28,29], and p,p'-DDE was considered as a relevant marker
of POPs [30]. The specific aim of the present study was to
compare the actual level of AhR mediated dioxin-likePage 2 of 13
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and Inuit study groups, and to evaluate whether the tested
dioxin-like activity was correlated to CB-153 or p,p'-DDE.
2. Methods
2. 1. Study groups and sampling
The Inuedo source populations encompassed women and
their male spouses who had antenatal care visits from May
2002 through February 2004 at the local hospitals in
Greenland, Warsaw, Poland and Kharkiv, Ukraine [26].
An established cohort of Swedish fishermen was also
included [31]. The study was approved by the local ethical
committees representing all participating populations
and all subjects signed an informed consent. The subjects
of the present study were adult males randomly selected
from the source populations. Demographic and lifestyle
factors such as age, body mass index (BMI), alcohol con-
sumption, intake of seafood, coffee and smoking habits
were collected by questionnaires (Table 1) [26,27].
This study included in total 338 blood samples taken
from males from Greenland (75), Sweden (78), Warsaw
(99) and Kharkiv (86). Venous blood samples were col-
lected in 10 ml vacuum tubes and after centrifugation the
serum was transferred to Nunc tubes and stored at -80°C
until analyzed [27].
2. 2. Determination of CB-153 and p,p'-DDE in serum
Serum concentrations of CB-153 and p,p'-DDE were deter-
mined using GC-MS after solid phase extraction and on-
column degradation of lipids. CB-153 and p,p'-DDE levels
were adjusted for serum lipids analyzed by enzymatic
methods [27,31]. Levels of detection, coefficients of vari-
ation (CV) and participation in quality control programs
have been described in detail elsewhere [27]. All analysis
of CB-153 and p,p'-DDE were performed at the Depart-
ment of Occupational and Environmental Medicine, Uni-
versity of Lund, Sweden.
2. 3. AhR-CALUX assay
2. 3.1. Sample preparation
The extraction of serum sample to obtain the fraction con-
taining lipophilic POPs for AhR-CALUX activity measure-
ments was performed at a certified laboratory, Le Centre
de Toxicologie, Sainte Foy, Quebec, Canada. Serum sam-
ples (2 ml) were mixed with an aqueous solution of
ammonium sulfate and ethanol (1:1) and then extracted
with hexane. Extracts were concentrated and cleaned by
elution through two columns containing Florisil. The
details of extraction has been described elsewhere [32].
The extracts dissolved in 500 µl hexane were stored at -
80°C until analyzed.
Table 1: Characteristics of the men in the study groups
Greenland n = 75 Warsaw n = 99 Sweden n = 78 Kharkiv n = 86 All n = 338
Age (years) median 30 30 46 26 32
min-max 23–47 18–46 24–67 16–45 16–67
BMI (Kg/m2) median 26 26 26 24 25
min-max 19–38 12–58 22–37 19–36 12–58
Alcohol (drink/
week)
median 2.0 3.5 n.a 2.5 3.00
min-max 0–35 0–30 0.2–15 0–35
Smoking (ever) % 87 49 40 82 68
Seafood (days/
week)
median 2.0 1.0 n.a 4.0 2.0
min-max 0–9.0 0–9.0 1.0–9.0 0–9.0
Coffee (cups/day) median 3.0 2.0 n.a 2.0 2.0
min-max 0–20 0–6.0 1.0–7.0 0–20
Total 
testosterone 
(nmol/l)
median 14 13 12 18 14
min-max 3.2–75 6.5–23 4.2–28 8.4–32 3.2–32
Estradiol (nmol/l) median 59 72 67 81 71
min-max 31–88 45–296 25–155 33–144 25–296Page 3 of 13
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The serum extracts were thawed and evaporated to near
dryness at 30°C under the gentle stream of nitrogen. The
sample solvent, 10 µl DMSO: H2O (5:5, v/v), was added
to each sample vial and stored overnight at room temper-
ature. After giving the samples a quick spin (1000 rpm, 25
sec.), 500 µl α-minimal essential medium (α-MEM, Gib-
coBRL, UK) was added, mixed completely and transferred
to two new test tubes (250 µl/tube) each containing 417
µl supplemented α-MEM (α-MEM plus 10% fetal calf
serum (FCS, GibcoBRL, UK), 64 µg/ml garamycin (Scher-
ing-Plough, Brussels, Belgium)) with or without the 60
pM (EC50) (see 2.3.3) TCDD (98%, Cambridge Isotopes
Laboratories Inc., USA), respectively. The final serum
extract was equal to 150 µl serum per well (96- well plate)
which was shown to be in the linear range of the AhR
mediated luciferease activity (Bonefeld Jorgensen and
Long, manuscript in prep.). All the processes were pro-
tected from light.
2.3.3. AhR-CALUX bioassay
The stable transfected mouse hepatoma cell line
Hepa1.12cR carrying the AhR-luciferase reporter gene
(kindly provided by M.S. Denison (University of Califor-
nia, USA)), induces luciferase in an AhR-, time- and dose-
dependent manner [23]. In each independent experiment,
a dose-response of TCDD (dissolved in DMSO and subse-
quently diluted in the supplemented α-MEM) was per-
formed at concentrations ranging from 2 × 10-12 to 5 × 10-
9 M (see additional file 1: TCDD dose-response curve for
AhR mediated luciferase activity). The maximum effect
concentration was 1000 pM, and the half maximum effect
concentration (EC50(TCDD)) was calculated to be 60 pM by
fitting the dose-response data into a three parameter sig-
moidal Hill curve using Sigma Plot (SPSS, Chicago, IL,
USA). The minimal detection limit was 64 fg/well with an
intra CV of 5–10% and an inter CV of 10–20%. The sam-
ple solvent controls (+/- EC50(TCDD)) consisted of sample
solvent treated like the serum extract but without the
extract, and the EC50(TCDD) was used as parallel positive
control in each assay on each plate.
AhR agonistic effect (AhRag) was determined by exposure
of the cells to serum extracts alone, and the competitive
AhR effect (AhRcomp) was determined upon co-exposure
with serum extract and 60 pM TCDD (EC50). The AhR-
CALUX assay can be described shortly as follows: The
Hepa1.12cR cells were seeded into sterile 96-well white
CulturPlate™ (Packard Instruments) at 6 × 104 cells per
well and cultured in supplemented α-MEM containing
400 µg/ml geneticin (G418, Sigma-Aldrich) at 37°C, 5%
CO2 in 95% humidified air for 24 h, allowing cells to
reach 90–100% confluence. Then media were removed
and the cells were in parallel exposed to the serum extract,
serum extract plus 60 pM TCDD, and sample solvent con-
trols in a total volume of 100 µl per well in triplicate. After
exposure for 4 h, cells were washed with phosphate-buff-
ered saline (PBS, pH 7.4) followed by addition of cell
lyses buffer. Luciferase activity and cell protein were deter-
mined as described [33]. The luciferase activity was
expressed in relative light units per microgram protein
(RLUs/µg protein). The average intra-sample CV was 11%
and the inter CV of solvent control was 19%.
No cell toxicity on Hepa1.12cR cells was determined by
the CellTiter 96 assay from Promega (Madison. WI, US)
[33] after exposure to the tested serum extract.
The determinations of AhR activity was in good inter-lab
precision, as determined from the results of interlabora-
tory comparison program (Second round of interlabora-
tory comparison of dioxin-like compounds in food using
bioassay, Orebro, Sweden).
2. 4. Calculation and statistical analysis
In the independent assays the activity differences between
the triple serum extract determinations and their respec-
tive solvent controls (% agonistic, % antagonistic and %
additive/synergistic, Table 2) were evaluated using the
Student t-test (Microsoft Excel).The data was given as RLU
per ml serum and the value of the solvent controls was
6.67 RLU/ml serum.
The CALUX-based AhR-TEQs values of serum extract were
obtained by interpolation of AhRag values onto the
TCDD dose-response sigmodal Hill curve (see additional
file 1: TCDD dose-response curve for AhR mediated luci-
ferase activity). Only the AhRag values being significantly
higher than the solvent control and in the linear range of
the TCDD dose-response curve were used to calculate
AhR-TEQ.
The natural logarithmic transformed AhR-mediated activ-
ities and markers of POPs improved the normality
(checked by Q-Q plots) and homogeneity of variance, and
the statistical analysis was performed on the ln-trans-
formed data. The comparisons of means between the dif-
ferent variables (POP markers, AhRag, AhR-TEQ and
AhRcomp) were performed with One-way ANOVA test.
When ANOVA showed statistical significant difference
complementary multiple comparison ad hoc tests was per-
formed. Test for equal variances was performed with Lev-
ene's test. The least-significant difference (LSD) test was
used if the variables have equal variance; otherwise
Dunett T3 test was used.
Bivariate correlations were evaluated by Spearman's rank
correlation test. The overall association between the POP
markers and AhR-mediated activities across the study
groups (combined data) was assessed by comparing thePage 4 of 13
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regression analysis.
Up to date few studies on dioxin-like activities in human
serum have been reported [34-37], and thus the knowl-
edge is limited about which dietary or other life-style
determinants might affect serum dioxin-like activity. Our
hypothesis is that potential determinants of POP bioaccu-
mulation might also be potential determinants for serum
dioxin-like activity. Guided by the literature [38] and also
from the assessment of the main Inuendo study popula-
tions [26,27], age and seafood are known determinants
affecting the POP serum level. Moreover, lifestyle charac-
teristics (Table 1) were evaluated as potential determi-
nants of AhRag, AhR-TEQ and AhRcomp levels. Multiple
linear regression model was used to assess the impact of
the POP biomarkers on AhRag, AhR-TEQ and AhRcomp.
The impact of potential confounders were evaluated by
entering blocks of variables together with either CB-153
or p,p'-DDE as follows: in the first step, age and seafood
intake were included in the model, and in the second step
additionally smoking status, BMI, coffee intake and alco-
hol consumption were included in the model. Due to
many missing values on the potential confounders the
number of available observations in the confounder anal-
yses are much smaller than in the unadjusted analysis on
the full dataset (full dataset: n = 338, first step of con-
founders: n = 232, second step: n = 164). A reduction of
the number of observations with more than 50% might
introduce serious selection problems, and hence the con-
founder analyses might lack greater validity.
The AhR activities were tested in protein free serum
extract, which may still contain endogenous steroids, thus
testosterone (total and free) and estradiol [39] were fur-
ther included in the linear regression model on the com-
bined study group data.
The inter-population variations in POP markers, AhRag,
AhR-TEQ and AhRcomp serum level were also assessed by
Table 2: AhR-mediated serum activities, TCDD equivalents and lipid adjusted POP markers in serum
Greenland Warsaw Sweden Kharkiv All
AhRag*1 (RLU/ml 
serum)
N 75 99 78 86 338
Median 24 34 33 26 29
Min 6.6 11 8.0 8.8 6.6
Max 257 118 103 56 257
% agonist 92 100 95 100 97
AhR-TEQ*2 (pg/g 
lipid)
N 70 99 76 80 325
Median 197 312 428 337 310
Min 38 72 104 110 38
Max 1188 1054 1261 781 1261
AhRcomp*3 
(RLU/ml serum)
N 75 99 78 86 339
Median 8.3 6.4 6.2 5.5 6.8
Min 3.9 3.2 1.6 1.5 1.5
Max 16 9.1 10 11 16
% add/syn 41 3.0 6.4 18 16
%antagonist 2.7 8.0 12 34 14
CB-153 (ng/g 
lipid)
N 74 100 98 82 355
Median 220 16 210 47 78
Min 5.1 3.3 41 5.5 3.3
Max 5500 130 1500 200 5500
p,p'-DDE (ng/g 
lipid)
N 74 100 98 82 355
Median 630 570 240 880 560
Min 66 240 55 320 55
Max 13000 2100 2300 12000 13000
*1: AhRag: AhR activity of serum extract alone determined as the relative luciferase activity (RLU) per ml serum; Solvent background control = 6.67 
RLU/ml serum. The % agonistic indicates the % of samples eliciting a significant increase in AhR activity compared to the solvent control. *2 AhR-
TEQ (TCDD equivalents): The samples eliciting significantly agonistic activity was calculated by interpolation to the TCDD dose-response curve 
using the Sigmaplot program, given as pg/g serum lipid. *3 AhRcomp: AhR competitive activity of serum extract + 60 pM TCDD (EC50) given as RLU/
ml serum. EC50 solvent control = 6.67 RLU/ml serum; % add/syn and %antagonistic indicates the % of samples responding with a further increase or 
decrease of the EC50(TCDD) induced activity, respectively.Page 5 of 13
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ered as a potential confounder to make age-adjusted com-
parisons.
The statistical analysis was performed on SPSS 13.0 (SPSS
Inc. Chicago, IL, USA). The statistical significant level was
set to p ≤ 0.05.
3. Results
3.1. The basic characteristics and serum levels of CB-153 
and p,p'-DDE
The distributions of demographic and lifestyle factors
(Table 1) and the serum CB-153 and p,p'-DDE levels
(Table 2) of the 338 adult males in this study were similar
to that of the main Inuendo study population [26,27].
The Greenland and Swedish groups elicited higher CB-
153 level than the Kharkiv and Warsaw group, and the
level of CB-153 of Warsaw group was significantly lower
than the other groups (Table 2 and see additional file 2A:
Multiple comparisons of variables). The p,p'-DDE level in
Kharkiv was the highest, followed by Greenland and War-
saw, and the significant lowest level was found for the
Swedish fishermen (Table 2 and see additional file 2A:
Multiple comparisons of variables). As for the main study
[27], age adjustment did not change the pattern of differ-
ence for the POP markers between the study groups.
A higher correlation between serum concentration of CB-
153 and p,p'-DDE was found for the Greenlandic (rs =
0.94, p < 0.001) and Swedish groups (rs = 0.75, p < 0.001),
and lower correlations were observed for the Kharkiv (rs =
0.45, p < 0.001) and the Warsaw (rs = 0.27, p < 0.01) study
groups (see additional file 2B: Spearman's correlation
between serum AhR activities and the levels of CB-153
and p.p'-DDE).
3.2. Agonistic and competitive AhR activity in the four 
study groups
Almost all serum samples (97%) showed AhRag activity
significantly higher than the solvent control (Table 2).
The AhRag activity and AhR-TEQ differed significantly
among the study groups (Table 2 and see additional file
2A: Multiple comparisons of variables): the Greenland
and Kharkiv groups had lower AhRag medians than Swe-
den and Warsaw groups (Fig. 1A and see additional file
2A: Multiple comparison of variables), and the AhR-TEQ
median level of Greenland group was significantly lower
than that of the European study groups (Table 2, Fig 1B
and see additional file 2A: Multiple comparisons of varia-
bles).
The Greenlandic AhRcomp activity, eliciting the highest
incidence (41%) of sample with further increasing TCDD
induced AhR activity, was significantly higher than for the
European groups (Table 2, Fig. 1C and see additional file
2A: Multiple comparisons of variables), whereas the
Kharkiv group showed the highest frequency of sample
with antagonistic effect on TCDD induced AhR activity
(Table 2).
Compared to the crude data, the pattern of differences of
AhRag, AhR-TEQ and AhRcomp between the study groups
did not change after adjustment for age (data not shown).
3.3. Associations between AhRag, AhR-TEQ, AhRcomp and 
the POP markers
Significant inverse correlation (rs = -0.30, p < 0.01)
between AhRcomp and CB-153 was observed for the
Kharkiv group (Fig. 2 and see additional file 2B: Spear-
man's correlation between serum AhR activities and the
levels of CB-153 and p.p'-DDE). Neither AhRag nor AhR-
TEQ was found to correlate to the two POP markers for
any of the study groups (see additional file 2B: Spear-
man's correlation between serum AhR activities and the
levels of CB-153 and p.p'-DDE).
Adjustment for potential confounders in the multiple
regression models did not change the strength of associa-
tion between exposure variables (POP markers) and out-
come variables (AhR-mediate activities) when compared
with the unadjusted models. Further adjustment for
endogenous testosterone and estradiol neither changed
this pattern (data not shown).
3. 4. Multiple regressions of AhR-mediated activities on 
POP markers across the study groups
Scatter plots of AhR-mediated activities against POP
markers for the study groups are shown in Figure 3. Mul-
tiple regression analysis showed homogeneity of associa-
tions between CB-153 or p,p' -DDE and AhRag and AhR-
TEQ as well as AhRcomp and p,p' -DDE across the study
groups (Table 3), i.e. parallel regression lines among study
groups. Furthermore, a model with parallel regression
lines showed a significant differences between the inter-
cepts of the study groups (Table 3), thus the differences in
AhRag/AhR-TEQ/AhRcomp between study groups still
exist after adjustment for CB-153 or p,p' -DDE. However,
heterogenetic associations between serum CB-153 and the
AhRcomp across the study groups were found (Table 3).
Thus the difference of AhRcomp between the study groups
was correlated to the CB-153 level, which supports the
negative correlation between AhRcomp and CB-153 for
the Kharkiv group.
4. Discussion
In the present study we measured the integrated AhR
mediated activity in the lipophilic serum fraction contain-
ing POPs using the mechanistically based AhR-CALUX
bioassay. No consistent correlation between the POP
markers (CB-153 and p,p'-DDE) and AhR mediated activ-Page 6 of 13
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incidence of antagonistic AhRcomp activity, a negative
correlation between AhRcomp and CB-153 was found in
Kharkiv group. This finding is supported by earlier reports
that CB-153 and associated compounds antagonized
TCDD induced AhR action [40,41], as well as observation
in our laboratory (Long and Bonefeld-Jorgensen, manu-
script in prep.).
The study showed that 97% of the serum samples across
the study groups elicited significant agonistic AhR activity.
The median of AhRag activity in the Warsaw and Swedish
groups reached higher level compared to the Kharkiv and
the Greenlandic groups. Moreover, the median levels of
AhR-TEQ of the European study groups were significantly
higher than that of the Greenlandic Inuit's having high
burden of both CB-153 and p,p'-DDE. We do not exactly
AhR-CALUX activities of the study groupsFigure 1
AhR-CALUX activities of the study groups. (A) Agonistic activity of serum extracts alone (AhRag), (B) AhR-TEQ (AhR-
CALUX- TCDD toxic equivalent) and (C) competitive AhR activity upon cotreatment with 60pMTCDD (EC50) and serum 
extract (AhRcomp). For the AhRag the outliers ranging from 86.01 to 111.28 RLU/ml serum and extreme values (117.87 – 
257.13 RLU/ml serum) are not shown. The reference lines of the respective solvent controls ± SD (6.67 ± 0.74) are given as 
dashed lines.
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Environmental Health: A Global Access Science Source 2006, 5:14 http://www.ehjournal.net/content/5/1/14know the dietary habit of the Warsaw study group. How- ever, relatively high level of dioxins and DLCs were
Table 3: Multiple regressions of the combined study groups
Response variable Homogeneity of slope (p 
value)
Common slope, Estimate 
(SE), p value
Common intercept (p 
value)
Adjusted R square
AhRag (n = 327)
CB-153 0.95 -0.03 (0.04), 0.43 0.001 0.05
p,p'-DDE 0.28 -0.02 (0.05), 0.70 0.001 0.05
AhR-TEQ (n = 324)
CB-153 0.54 0.11(0.04), 0.77 < 0.001 0.20
p,p'-DDE 0.99 0.08(0.05), 0.07 < 0.001 0.20
AhRcomp (n = 327)
CB-153 0.01 -* -* -*
p,p'-DDE 0.80 -0.03 (0.03), 0.24 < 0.001 0.18
Both AhR activities and POP markers are ln transformed. Homogeneity of slope: test for homogeneity of association between exposure variables 
and outcome variables across the study group (p > 0.05, accept the hypotheses of homogeneity of slope). Common slope: the estimated common 
slope across study groups assuming homogeneity (p > 0.05, accept the hypotheses that slope equals to zero). Common intercept: test of a common 
intercept across study groups assuming a common slope (p > 0.05, accept the hypotheses having common intercept across the study groups). 
Adjusted R square assumes a common slope. *: Since heterogeneity of slope exists between CB-153 and AhRcomp across the study groups, i.e. 
there were country differences in the association of CB-153 and AhRcomp, no further evaluation was performed.
The relationship between AhRcomp activity and CB-153 for the Kharkiv groupFigu  2
The relationship between AhRcomp activity and CB-153 for the Kharkiv group. Scatterplot of correlation between 
serum AhRcomp and CB-153. For definitions of AhRcomp see legend to Table 2. Ln-transformed data was used. RLU: relative 
luciferase units.
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The association between AhR activity and POP markers in the study groups. The AhR activities are given for the 
four country based study groups as relation between (A) AhRag and CB-153, (B) AhRcomp and CB-153, (C) AhRag and p,p'-
DDE, (D) AhRcomp and p,p'-DDE. Ln-transformed data was used. For the definition of AhRag and AhRcomp, see the legend to 
Table 2. RLU: relative luciferase units. 
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ronment [42,43]. The relatively higher AhRag and AhR-
TEQ in the Swedish study group may be caused by high
exposure to dioxins and/or dioxin-like PCBs (DL-PCBs)
[8].
Except for a recent study of Slovakia males [44], the AhR-
TEQ in the present study was relatively higher (2~8 fold)
than other similar studies [35,37], which can be related to
the difference in exposure time (4 hours versus 24 hours).
During the optimal exposure time (4 h) of Hepa1.12cR
cell line used in this study [45,46], other active com-
pounds in the lipophilic serum fraction such as polycyclic
aromatic hydrocarbons (PAHs), polybrominated biphe-
nyls (PBBs), polyhalogenated naphthalenes may interact
and activate the AhR in the CALUX- bioassay. In other
studies e.g. using rat H4IIE cells, the labile AhR agonists in
the serum such as some PAHs and other chemicals may be
degraded or metabolized during the 24 hours of exposure
resulting in a relatively lower AhR response [47]. PAHs
elicite high AhR response after short exposure [47,48],
nevertheless, in the present study the PAHs level would be
very low in the serum extract because the purification
method was not built specifically for these molecules. We
do not assume that the endogenous compounds play a
major role in our AhR response data because fatty acids
and other nonclassical AhR ligands may be removed from
the crude extract in the cleanup procedure [24,32]. How-
ever, we can not exclude that some organic endogenous
AhR inducers possibly passed through the purification
columns and contribute to the AhR response [49]. Owing
to the possible existence of cross-talk between AhR and ER
and AR, it can not be excluded whether the xenohor-
mones and/or endogenous sex hormones (estradiol and
testosterone) influence the observed AhR response.
Although the influence is expected to be of minor impor-
tance since no correlation between the sex hormones and
AhR-mediated activity across the study groups were
found. The extract in this study contains most organo-
chlorine compounds including organochlorine pesticides
like hexachlorobenzene (HCB) that can contribute to the
AhR response [50]. Future investigations are required to
elucidate the profile of serum compounds contributing to
the AhR-CALUX response. Possibly, the gender might also
influence the lipid adjusted AhR-TEQ level since the par-
ticipants in other studies were female [35,36].
The differences in AhRag/AhRcomp activities among the
study groups suggest that there are regional differences in
profiles of POPs, PAHs and/or other lipophilic AhR acti-
vating compounds. The higher frequency of samples fur-
ther increasing the TCDD induced AhR activity in Inuit's
indicated the presence of compounds which can enhance
the effect of the TCDD, the most potent AhR ligand. Con-
sidering the further increase of AhRcomp using the TCDD
dose-response curve (see additional file 2: TCDD dose-
response curve for AhR mediated luciferase activity), the
median AhR-TEQ determined in serum of the correspond-
ing subgroup (n = 180) was calculated to be 1.3 ng/g lipid,
suggesting an increasing risk from DLCs when a strong
AhR ligand exists simultaneously in the body.
Studies of Inuit populations in Canada support in general
the use of CB-153 as a surrogate marker of exposure to
non-DL-PCBs present in the Arctic food-chain [51]. How-
ever, the level of coplanar and non-coplanar PCBs was
shown to differ between Canadian Inuits and Caucasian
[32,52]. For non-occupational exposed Inuit populations
in the Arctic Quebec the ratio between coplanar PCBs (e.g.
CB-126 or CB-169) and the non-coplanar PCB (e.g. CB-
153) of Inuits was lower than that of the Caucasian refer-
ence group [52]. Moreover, DL-PCBs contributed to a
larger extent to the chemical calculated TEQ than PCDD
and PCDFs, with the mono-ortho coplanar CB-118 as
major contributor for the total toxicity [52]. Similar differ-
ence may also exist for the populations included in this
study, supporting the higher AhRag or AhR-TEQ level of
Europeans.
Previously, CB-153 was reported to be highly correlated
with calculated chemical-derived total TEQs and/or
PCDD/PCDFs TEQs and/or non-ortho PCBs TEQs [29]. It
should be noted that the chemical derived TEQ was calcu-
lated according to analytical chemistry data of some con-
geners under the assumption of additivity. Even though
additive effects of PCDDs/PCDFs/DL-PCBs are predomi-
nating, non-additive effects such as antagonism and syn-
ergism can apply to interactions between individual DLCs
in a complex mixture [53]. The TEQ based on the AhR-
CALUX bioassay represents the integrated sum of dioxin-
like activities including additive, synergistic and antago-
nistic effect. Few epidemiology studies have reported anal-
ysis of association between di-ortho PCB (including CB-
153) and CALUX-TEQ, and the results were contradictory.
A positive correlation was reported by Pauwels et al [35].
However, a recent report of the potential of the CALUX
bioassay to estimate TEQ in plasma of Italian women with
background exposure to dioxin and DLCs showed no sig-
nificant correlation between CALUX-TEQ and the sum of
four major PCB congeners (CB-118, CB-138, CB-153, CB-
180) [36]. Similar result was reported in a Belgium study
[34]. The contradictory results may be related to the differ-
ences in study design, sample selection (gender and age of
subjects, serum or plasma), composition and concentra-
tions of bio-accumulated compounds in the blood and/or
different sample extraction methods used in the CALUX
bioassay as discussed [36,49,54]. Moreover, an important
part of dioxin-like activity is elicited especially by PCDD/
Fs when their concentration is high in the sample [55].
One can find some correlations between PCB levels andPage 10 of 13
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tions of PCDD/Fs are low or comparable in different
cohorts [34,56].
5. Conclusion
97% of analyzed samples elicited significant agonistic
AhR induced activity. The level of AhR mediated activities
differed among the study groups. European groups elic-
ited higher AhR-TEQ than the Greenland Inuits, suggest-
ing a higher exposure to DLCs. In addition, dietary habits/
life style factors and the genetic difference between Inuits
and Caucasians [57] may also be taken into account.
No consistent significant correlation between CB-153 and
p,p'-DDE and AhR activities was observed and these two
selected POP markers cannot alone predict the contribu-
tion of POPs, PAHs, and other lipophilic xenobitics to
serum dioxin-like activity. Other more sensitive and spe-
cific tentative markers such as DL-PCBs (e.g. the mono-
ortho congener CB-118 and CB-156) should be included
in future epidemiology studies.
Since some less persistent compounds might contribute
to the AhR-CALUX response due to the selected fractiona-
tion technique and that in vitro AhR-CALUX detects the
overall dioxin-like response, it is not clear which com-
pounds contribute to the observed dioxin-like activity.
Thus the serum dioxin-like activity determined in this
study must be interpreted as an independent parameter,
complementary to chemical data. It should be kept in
mind that the AhR-CALUX bioassay is not a substitute of
actual chemical analysis by GC-MS techniques but pro-
vide biologically relevant results and normally is utilized
as first tier screening tool followed by the chemical analy-
sis to identify specific response compounds [24]. AhR-
CALUX bioassay provides an overall biological response/
potency of mixture, whereas chemical analysis provides
the concentration of specific compounds in the mixture.
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